SLCO4C1 Promoter Methylation Is a Potential Biomarker for Prognosis Associated With Biochemical Recurrence-Free Survival After Radical Prostatectomy
Clinical Epigenetics - Germany
doi 10.1186/s13148-019-0693-2
Full Text
Open PDFAbstract
Available in full text
Date
July 9, 2019
Authors
Publisher
Springer Science and Business Media LLC